Ifs, bots and maybes
Our future robot overlords are playing the long game
Read Moreby John Pinching | Apr 19, 2024 | Web Exclusives | 0
Our future robot overlords are playing the long game
Read Moreby John Pinching | Jan 15, 2024 | News | 0
CellVoyant’s platform combines AI with live cell imaging
Read Moreby John Pinching | Sep 28, 2023 | News | 0
Collaboration will enable teams across the organisation to increase clinical research innovation
Read Moreby John Pinching | Jun 29, 2023 | News | 0
Partnership establishes several influenza therapy targets using artificial intelligence
Read Moreby John Pinching | Dec 15, 2022 | News | 0
AI processes could detect early-stage lung cancer from unstructured medical notes
Read Moreby John Pinching | Dec 14, 2022 | News | 0
The partnership combines systems in order to identify subtle phenotypic changes in living cells
Read Moreby John Pinching | Nov 22, 2022 | News | 0
€20m financing will focus on treatment pathways, new partnerships and team expansion
Read Moreby John Pinching | Nov 10, 2022 | News | 0
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK
Read Moreby John Pinching | Sep 7, 2022 | News | 0
Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
Read Moreby John Pinching | Sep 2, 2022 | News | 0
AI company has its breast cancer and colorectal therapies approved for use in Europe
Read Moreby John Pinching | May 9, 2022 | News | 0
Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption
Read Moreby John Pinching | Mar 24, 2022 | News | 0
Collaboration will focus on AI analysis of flu progression, immune responses and the development of new vaccines
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479